Ciltacabtagene autoleucel,Pomalidomide,Bortezomib,Dexamethasone,Daratumumab
Janssen
['mmsm']
aa11: many asked me if dkd would make any difference if it was used as a control arm!! my answer: there are no studies that proved which triplet is best! however, we know that car-t is better than triplet therapy in early relapse myeloma #mmsm #myeloma #medtwitter #asco23 
Associate Professor,Plasma Cell disorder program Director, Division of HMCT/University of Kansas Medical Center, no COI, #USMIRC Founder, #mmsm @KUMedCenter